Zobrazeno 1 - 10
of 289
pro vyhledávání: '"TOSHIYUKI SUMI"'
Autor:
Toshiyuki Sumi, Motoki Sekikawa, Yuta Koshino, Daiki Nagayama, Yuta Nagahisa, Keigo Matsuura, Naoki Shijubou, Koki Kamada, Keito Suzuki, Takumi Ikeda, Haruhiko Michimata, Hiroki Watanabe, Yuichi Yamada, Koichi Osuda, Yusuke Tanaka, Hirofumi Chiba
Publikováno v:
Thoracic Cancer, Vol 15, Iss 20, Pp 1572-1581 (2024)
Abstract Background The efficacy of anti‐CTLA‐4 antibody (ipilimumab) plus anti‐programmed cell death 1 antibody (nivolumab) in treating advanced non‐small cell lung cancer (NSCLC) is impeded by an elevated risk of severe immune‐related adv
Externí odkaz:
https://doaj.org/article/ce7d0e0952334636b66f0569062931cd
Autor:
Yasuyuki Ikezawa, Ryo Morita, Hidenori Mizugaki, Kazunari Tateishi, Keiki Yokoo, Toshiyuki Sumi, Hajime Kikuchi, Yasuo Kitamura, Atsushi Nakamura, Maki Kobayashi, Mari Aso, Nozomu Kimura, Fumiaki Yoshiike, Furuta Megumi, Hisashi Tanaka, Motoki Sekikawa, Tsutomu Hachiya, Keiichi Nakamura, Fumihiro Hommura, Noriaki Sukoh, Kenichiro Ito, Takashi Kikuchi, Toshihiko Agatsuma, Hiroshi Yokouchi
Publikováno v:
Cancer Medicine, Vol 13, Iss 14, Pp n/a-n/a (2024)
Abstract Background Selecting pembrolizumab monotherapy (MONO) or pembrolizumab plus platinum‐based chemotherapy (COMB) for patients with nonsmall cell lung cancer (NSCLC) and high programmed death‐ligand 1 (PD‐L1) expression is an important is
Externí odkaz:
https://doaj.org/article/9abe2da6e7c64c909348f0fdd32c3056
Autor:
Ken-ichi Honda, Masato Miyama, Yuko Nishii, Reiko Tasaka, Yusuke Nakano, Naohiko Umesaki, Takeshi Fukuda, Tomoyuki Ichimura, Tomoyo Yasui, Toshiyuki Sumi
Publikováno v:
Journal of Medical Case Reports, Vol 18, Iss 1, Pp 1-5 (2024)
Abstract Background In patient assessment for recurrence of neoplasia, a biomarker that shows an elevated serum value before the first treatment is a candidate for follow-up examination. The biomarker squamous cell carcinoma antigen is usually utiliz
Externí odkaz:
https://doaj.org/article/8ca9c1c97186434ea3c26e94316cd4d1
Publikováno v:
Respirology Case Reports, Vol 12, Iss 3, Pp n/a-n/a (2024)
Key message The sputum colour in patients with severe pneumonia needs to be considered during diagnosis.
Externí odkaz:
https://doaj.org/article/c331ed5a7cfc4721886fec467f63f81b
Publikováno v:
Respirology Case Reports, Vol 12, Iss 1, Pp n/a-n/a (2024)
Abstract Skeletal muscle metastasis of lung cancer is rare. However, clinicians should be aware that tumour‐induced nerve compression symptoms may develop.
Externí odkaz:
https://doaj.org/article/6c28431c96ff47c088443c6f6847cf3b
Autor:
Rieko Ishibashi, Ruka Koike, Yoriko Suda, Tatsuhiro Kojima, Toshiyuki Sumi, Toshiyuki Misawa, Kotaro Kizu, Yosuke Okamura, Takeru Ito
Publikováno v:
Inorganics, Vol 12, Iss 6, p 146 (2024)
Lanthanide elements such as europium exhibit distinctive emissions due to the transitions of inner-shell 4f electrons. Inorganic materials containing lanthanide elements have been widely used as phosphors in conventional displays. The hybridization o
Externí odkaz:
https://doaj.org/article/ff05a432f94b4afbb720d6d0e32cb5a3
Autor:
Haruhiko Michimata, Toshiyuki Sumi, Daiki Nagayama, Yuta Koshino, Hiroki Watanabe, Yuichi Yamada, Hirofumi Chiba
Publikováno v:
Respirology Case Reports, Vol 11, Iss 5, Pp n/a-n/a (2023)
Key message Perinatal cardiomyopathy presents similarly to dilated cardiomyopathy and should be suspected in perinatal women presenting with dyspnoea, even with no previous history of heart disease.
Externí odkaz:
https://doaj.org/article/0bf53ab5c535458eb1dcca49cc57c18e
Autor:
Kazuya Takeda, Toshiyuki Sumi, Yuta Nagahisa, Keigo Matsuura, Motoki Sekikawa, Hiroki Watanabe, Yuichi Yamada, Hirofumi Chiba
Publikováno v:
Allergy, Asthma & Clinical Immunology, Vol 18, Iss 1, Pp 1-4 (2022)
Abstract Background Biologics dramatically improve symptoms of severe asthma; however, various exacerbating factors may induce flare-up. Pneumocystis spp. have not been reported as a cause of asthma exacerbation during biologic use, although patients
Externí odkaz:
https://doaj.org/article/d80264ecffd740c69d3eb6d3e6499b1f
Autor:
Toshiyuki Sumi, Yuta Nagahisa, Keigo Matsuura, Motoki Sekikawa, Yuichi Yamada, Hisashi Nakata, Hirofumi Chiba
Publikováno v:
Thoracic Cancer, Vol 12, Iss 22, Pp 3072-3075 (2021)
Abstract A 66‐year‐old man with squamous cell carcinoma had been receiving chemoradiation therapy after stereotactic radiotherapy for brain metastases. Atezolizumab was initiated as second‐line therapy, after which the patient became progressio
Externí odkaz:
https://doaj.org/article/b19949a1ae4845508d85bac3487a9988
Autor:
Gaku Yamamoto, Hajime Asahina, Osamu Honjo, Toshiyuki Sumi, Atsushi Nakamura, Kenichiro Ito, Hajime Kikuchi, Fumihiro Hommura, Ryoichi Honda, Keiki Yokoo, Yuka Fujita, Satoshi Oizumi, Ryo Morita, Yasuyuki Ikezawa, Hisashi Tanaka, Nozomu Kimura, Takaaki Sasaki, Noriaki Sukoh, Taichi Takashina, Toshiyuki Harada, Hirotoshi Dosaka-Akita, Hiroshi Isobe, the Hokkaido Lung Cancer Clinical Study Group Trial
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-11 (2021)
Abstract Osimertinib is a standard of care therapy for previously untreated epidermal growth factor receptor mutation-positive non-small cell lung cancer. However, limited data exist regarding the efficacy and safety of osimertinib as a first-line th
Externí odkaz:
https://doaj.org/article/30fdf5599db64195b591b2c71f3f2250